Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 679-684

  Patecki, Margret ^a   Schaewen, Markus von ^a   Tkachuk, Sergey ^b   Jerke, Uwe ^a   Dietz, Rainer ^a   Dumler, Inna ^a,b   Kusch, Angelika ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cell proliferation; Co culture; Jak Stat pathway; Urokinase urokinase receptor

Indexed keywords

FOCAL ADHESION KINASE 1; JANUS KINASE 1; STAT1 PROTEIN; UROKINASE;

ANALYTIC METHOD; ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; ENZYME ANALYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JANUS KINASE 1; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; MUTATION; PHOSPHOTYROSINE; TYK2 KINASE; URINARY PLASMINOGEN ACTIVATOR;

EID: 34250166902     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.166     Document Type: Article

References (26)

1. Kunigal S., Kusch A., Tkachuk N., Tkachuk S., Jerke U., Haller H., and Dumler I. Monocyte-expressed urokinase inhibits vascular smooth muscle cell growth by activating Stat1. Blood 102 (2003) 4377-4383
2. Aaronson D.S., and Horvath C.M. A road map for those who don't know JAK-STAT. Science 296 (2002) 1653-1655
3. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3 (2002) 651-662
4. Dumler I., Weis A., Mayboroda O.A., Maasch C., Jerke U., Haller H., and Gulba D.C. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J. Biol. Chem. 273 (1998) 315-321
5. Kusch A., Tkachuk S., Haller H., Dietz R., Gulba D.C., Lipp M., and Dumler I. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction. J. Biol. Chem. 10 (2000) 1-5
6. Kiian I., Tkachuk N., Haller H., and Dumler I. Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway. Thromb. Haemost. 89 (2003) 904-914
7. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., and Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70 (1996) 4805-4810
8. Mittereder N., March K.L., and Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70 (1996) 7498-7509
9. Krishnan K., Pine R., and Krolewski J.J. Kinase-deficient forms of Jak1 and Tyk2 inhibit interferon alpha signaling in a dominant manner. Eur. J. Biochem. 247 (1997) 298-305
10. Shuai K., Stark G.R., Kerr I.M., and Darnell Jr. J.E. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261 (1993) 1744-1746
11. Meyer T., and Vinkemeier U. Nucleocytoplasmic shuttling of STAT transcription factors. Eur. J. Biochem. 271 (2004) 4606-4612
12. Kusch A., Tkachuk S., Lutter S., Haller H., Dietz R., Lipp M., and Dumler I. Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model. Biol. Chem. 383 (2002) 217-221
13. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
14. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
16. Salame M.Y., Samani N.J., Masood I., and deBono D.P. Expression of the plasminogen activator system in the human vascular wall. Atherosclerosis 152 (2000) 19-28
17. Carmeliet P., Moons L., Herbert J.M., Crawley J., Lupu F., Lijnen R., and Collen D. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 81 (1997) 829-839
18. Gordon D., Reidy M.A., Benditt E.P., and Schwartz S.M. Cell proliferation in human coronary arteries. Proc. Natl. Acad Sci. USA 87 (1990) 4600-4604
19. Nakashima O., Terada Y., Hanada S., Yamamoto K., Kuwahara M., Sasaki S., and Marumo F. Activated STAT1 suppresses proliferation of cultured rat mesangial cells. Kidney Int. 57 (2000) 2249-2257
20. Bromberg J.F. Activation of STAT proteins and growth control. Bioessays 23 (2001) 161-169
21. de Prati A.C., Ciampa A.R., Cavalieri E., Zaffini R., Darra E., Menegazzi M., Suzuki H., and Mariotto S. STAT1 as a new molecular target of anti-inflammatory treatment. Curr. Med. Chem. 12 (2005) 1819-1828
22. Barry S.P., Townsend P.A., Latchman D.S., and Stephanou A. Role of the JAK-STAT pathway in myocardial injury. Trends Mol. Med. 13 (2007) 82-89
23. Royer Y., Staerk J., Costuleanu M., Courtoy P.J., and Constantinescu S.N. Janus kinases affect thrombopoietin receptor cell surface localization and stability. J. Biol. Chem. 280 (2005) 27251-27261
24. Shushakova N., Tkachuk N., Dangers M., Tkachuk S., Park J.K., Zwirner J., Hashimoto K., Haller H., and Dumler I. Urokinase-induced activation of the gp130/Tyk2/Stat3 pathway mediates a pro-inflammatory effect in human mesangial cells via expression of the anaphylatoxin C5a receptor. J. Cell Sci. 118 (2005) 2743-2753
25. Shaw M.H., Freeman G.J., Scott M.F., Fox B.A., Bzik D.J., Belkaid Y., and Yap G.S. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J. Immunol. 176 (2006) 7263-7271
26. de Vries C.J.M., van Achterberg T.A.E., Horrevoets A.J.G., ten Cate J.W., and Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J. Biol. Chem. 275 (2000) 23939-23947